M‐MDSCs play a crucial role in reactivating dormant colorectal cancer cells to potential metastatic cells by secreting CCL2 that binds to the receptor CCR2 on these dormant cells and activates the JAK‐STAT3 signaling pathway that promotes the transition from dormant to highly metastatic cells.133. This evidence concerns the gene CCL2 and colorectal cancer.